Ductal Carcinoma In Situ of the Breast
- PMID: 26139969
- PMCID: PMC4484537
- DOI: 10.1007/s12262-013-0987-0
Ductal Carcinoma In Situ of the Breast
Abstract
Ductal carcinoma in situ (DCIS) of the breast is a potentially invasive neoplasm. Risk factors include high estrogen states such as use of oral contraceptive (OC) pills, nulliparity, advanced age at first birth, and also family history and genetic mutations. The incidence of this usually clinically silent condition has risen in the past few decades due to widespread screening and diagnostic mammography, with final diagnosis confirmed by biopsy. At present, treatment options include total or simple mastectomy or lumpectomy with radiation. Adjuvant therapy includes antiestrogens like tamoxifen and human epidermal growth factor receptor 2 (HER2) suppression therapy. With the latest advances in chemotherapy and better understanding on the pathogenesis of the lesion, it is anticipated that more effective modalities of treatment may soon be available.
Keywords: Ductal carcinoma in situ; Lumpectomy; Mastectomy; NSABP trials.
Similar articles
-
Treatment of ductal carcinoma in situ: an uncertain harm-benefit balance.Prescrire Int. 2013 Dec;22(144):298-303. Prescrire Int. 2013. PMID: 24600734 Review.
-
Optimal management of ductal carcinoma in situ of the breast.Surg Oncol. 2003 Dec;12(4):221-40. doi: 10.1016/S0960-7404(03)00031-8. Surg Oncol. 2003. PMID: 14998563 Review.
-
Ductal carcinoma in situ of the breast: a surgical perspective.Int J Surg Oncol. 2012;2012:761364. doi: 10.1155/2012/761364. Epub 2012 Sep 4. Int J Surg Oncol. 2012. PMID: 22988495 Free PMC article.
-
Ductal carcinoma in situ (DCIS) of the breast: evolving perspectives.Cancer Treat Rev. 2000 Apr;26(2):103-25. doi: 10.1053/ctrv.1999.0149. Cancer Treat Rev. 2000. PMID: 10772968 Review.
-
Tamoxifen in ductal carcinoma in situ.Semin Oncol. 2006 Dec;33(6):647-9. doi: 10.1053/j.seminoncol.2006.08.019. Semin Oncol. 2006. PMID: 17145343 Review.
Cited by
-
MiRNA expression deregulation correlates with the Oncotype DX® DCIS score.Breast Cancer Res. 2022 Sep 12;24(1):62. doi: 10.1186/s13058-022-01558-4. Breast Cancer Res. 2022. PMID: 36096802 Free PMC article.
-
Effects of Atrial Natriuretic Peptide on p53 and Estrogen Receptor in Breast Cancer Cells.Biores Open Access. 2017 Oct 1;6(1):141-150. doi: 10.1089/biores.2017.0009. eCollection 2017. Biores Open Access. 2017. PMID: 29098120 Free PMC article.
-
The effects of turmeric (curcumin) on tumor suppressor protein (p53) and estrogen receptor (ERα) in breast cancer cells.Breast Cancer (Dove Med Press). 2017 Mar 10;9:153-161. doi: 10.2147/BCTT.S125783. eCollection 2017. Breast Cancer (Dove Med Press). 2017. PMID: 28331366 Free PMC article.
-
The regulation of steroid receptors by epigallocatechin-3-gallate in breast cancer cells.Breast Cancer (Dove Med Press). 2017 May 24;9:365-373. doi: 10.2147/BCTT.S131334. eCollection 2017. Breast Cancer (Dove Med Press). 2017. PMID: 28579831 Free PMC article.
-
Monitoring Progression of Ductal Carcinoma In Situ Using Photoacoustics and Contrast-Enhanced Ultrasound.Transl Oncol. 2019 Jul;12(7):973-980. doi: 10.1016/j.tranon.2019.04.018. Epub 2019 May 20. Transl Oncol. 2019. PMID: 31121489 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous